{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:40:52Z","timestamp":1767829252087,"version":"3.49.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/tp.0000000000001258","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:40:35Z","timestamp":1467632435000},"page":"63-73","source":"Crossref","is-referenced-by-count":10,"title":["Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys"],"prefix":"10.1097","volume":"101","author":[{"given":"Agnes M.","family":"Azimzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrooz S.","family":"Kelishadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Ngoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Welty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Avon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitch","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Hershfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Kronfli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Burdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210211","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI41861","article-title":"Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys","volume":"120","author":"Kelishadi","year":"2010","journal-title":"J Clin Invest"},{"key":"R2-17-20210211","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nm1673","article-title":"B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med"},{"key":"R3-17-20210211","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1172\/JCI34236","article-title":"B cell depletion: a novel therapy for autoimmune diabetes?","volume":"117","author":"Bour-Jordan","year":"2007","journal-title":"J Clin Invest"},{"key":"R4-17-20210211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"R5-17-20210211","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/TP.0b013e3181a235fd","article-title":"A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation","volume":"87","author":"Tyd\u00e9n","year":"2009","journal-title":"Transplantation"},{"key":"R6-17-20210211","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.tp.0000190099.62847.e6","article-title":"Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms","volume":"81","author":"Azimzadeh","year":"2006","journal-title":"Transplantation"},{"key":"R7-17-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0966-3274(03)00059-5","article-title":"Anti-CD20 treatment depletes B cells in blood and lymphatic tissue of cynomolgus monkeys","volume":"12","author":"Schr\u00f6der","year":"2003","journal-title":"Transpl Immunol"},{"key":"R8-17-20210211","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.4049\/jimmunol.179.4.2289","article-title":"CCR5 blockade modulates inflammation and alloimmunity in primates","volume":"179","author":"Schr\u00f6der","year":"2007","journal-title":"J Immunol"},{"key":"R9-17-20210211","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/01.tp.0000203170.77195.e4","article-title":"Simian parvovirus infection in cynomolgus monkey heart transplant recipients causes death related to severe anemia","volume":"81","author":"Schr\u00f6der","year":"2006","journal-title":"Transplantation"},{"key":"R10-17-20210211","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1600-6143.2005.01022.x","article-title":"Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates","volume":"5","author":"Azimzadeh","year":"2005","journal-title":"Am J Transplant"},{"key":"R11-17-20210211","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R12-17-20210211","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/IMT.15.54","article-title":"Update on CD40 and CD154 blockade in transplant models","volume":"7","author":"Zhang","year":"2015","journal-title":"Immunotherapy"},{"key":"R13-17-20210211","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-6143.2006.01622.x","article-title":"Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression","volume":"7","author":"Kean","year":"2007","journal-title":"Am J Transplant"},{"key":"R14-17-20210211","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R15-17-20210211","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2013.300","article-title":"Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies","volume":"85","author":"Halloran","year":"2014","journal-title":"Kidney Int"},{"key":"R16-17-20210211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14740330902750114","article-title":"Ten years of rituximab in NHL","volume":"8","author":"Winter","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R17-17-20210211","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"R18-17-20210211","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-17-20210211","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"R20-17-20210211","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1385\/IR:27:2-3:443","article-title":"The role of t\/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses","volume":"27","author":"Noorchashm","year":"2003","journal-title":"Immunol Res"},{"key":"R21-17-20210211","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.176.6.3498","article-title":"Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells","volume":"176","author":"Crawford","year":"2006","journal-title":"J Immunol"},{"key":"R22-17-20210211","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant"},{"key":"R23-17-20210211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-009-9327-3","article-title":"B cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis","volume":"30","author":"Thompson","year":"2010","journal-title":"J Clin Immunol"},{"key":"R24-17-20210211","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/TP.0b013e3181bbba1a","article-title":"BAFF may modulate the rate of B cell repopulation after rituximab therapy for acute renal transplant rejection","volume":"88","author":"Zarkhin","year":"2009","journal-title":"Transplantation"},{"key":"R25-17-20210211","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"R26-17-20210211","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"R27-17-20210211","doi-asserted-by":"crossref","first-page":"17ra10","DOI":"10.1126\/scitranslmed.3000116","article-title":"Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation","volume":"2","author":"Poirier","year":"2010","journal-title":"Sci Transl Med"},{"key":"R28-17-20210211","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am J Transplant"},{"key":"R29-17-20210211","first-page":"1245","article-title":"CDP7657, a monovalent Fab PEG anti-CD40L antibody, inhibits immune responses in both huSCID mice and non-human primates","volume":"62","author":"Wakefield","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"R30-17-20210211","first-page":"31","article-title":"General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases","volume":"27","author":"Schlaf","year":"2012","journal-title":"Histol Histopathol"},{"key":"R31-17-20210211","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1600-6143.2007.01815.x","article-title":"American Society of Transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:24:07Z","timestamp":1620977047000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201701000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001258","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}